Putnam BioRevolution ETF Rating $29.72 -0.31 (-1.03%) Closing price 09/23/2025 04:10 PM EasternExtended Trading$29.76 +0.04 (+0.13%) As of 09/23/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsShort InterestBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.74Holdings in SYNB have an aggregate rating of Moderate Buy based on 355 analyst ratings issued in the past year covering 21 companies (80.7% of the portfolio).SYNB Aggregate Price Target$29.72High Prediction$29.72Average Prediction$29.72Low Prediction$29.72Holdings in SYNB have an aggregate price target of $29.72 and a range of $29.72 to $29.72 covering 21 companies (80.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.07%TMOThermo Fisher Scientific$469.41-1.2%4.98 of 5 stars2.76$588.35 25.3%21Positive News5.94%CTVACorteva$69.48-0.4%4.8069 of 5 stars2.87$82.00 18.0%15Positive News5.28%ABBVAbbVie$222.88+0.1%4.7728 of 5 stars2.93$223.45 0.3%27Trending NewsAnalyst ForecastAnalyst Revision4.96%NVZMYNovozymes A/S$60.300.0%N/A2.3334.89%ASNDAscendis Pharma A/S$193.98-1.2%2.9825 of 5 stars3.00$244.36 26.0%15Positive News4.51%AZNAstraZeneca$75.97-2.0%3.0055 of 5 stars2.75$86.00 13.2%4Positive News4.44%BIOBio-Rad Laboratories$282.47-0.3%4.5411 of 5 stars2.60$333.50 18.1%5Analyst Revision4.37%NVDANVIDIA$178.43-2.8%4.9334 of 5 stars2.96$208.76 17.0%45Trending NewsAnalyst ForecastInsider Trade4.11%CDNSCadence Design Systems$366.30-1.9%4.5907 of 5 stars2.73$364.33 -0.5%15Positive NewsAnalyst Downgrade3.51%ICLRIcon$170.38-0.2%4.24 of 5 stars2.68$216.67 27.2%19Positive News3.48%DDDuPont de Nemours$77.52-0.9%4.4982 of 5 stars2.75$88.33 13.9%12Analyst Forecast3.46%LLYEli Lilly and Company$747.29-1.0%4.9978 of 5 stars2.67$939.61 25.7%24Trending News3.27%ZTSZoetis$142.43-1.5%4.8246 of 5 stars2.56$200.88 41.0%9Positive News3.13%NGVTIngevity$56.11-1.0%2.3949 of 5 stars2.50$58.00 3.4%2Positive News3.01%DHRDanaher$189.24-0.6%4.9889 of 5 stars2.85$245.91 30.0%20Positive NewsAnalyst Forecast3.00%REGNRegeneron Pharmaceuticals$567.89-4.7%4.7876 of 5 stars2.82$817.67 44.0%28Positive NewsGap Down2.53%DARDarling Ingredients$31.47+0.8%4.7068 of 5 stars2.78$43.57 38.4%9Positive News2.44%TECHBio-Techne$52.92-0.2%4.9837 of 5 stars2.77$70.42 33.1%13Positive News2.15%BIIBBiogen$139.31-1.0%4.6773 of 5 stars2.32$181.65 30.4%31Positive News2.14%AVTRAvantor$12.25-1.6%4.8697 of 5 stars2.47$15.50 26.6%15Positive News2.01%ARGXargenex$734.39-0.8%4.0731 of 5 stars3.08$789.20 7.5%24Analyst Upgrade This page (NYSEARCA:SYNB) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
